167 related articles for article (PubMed ID: 2575878)
1. Effects of fenoldopam on cecal blood flow and mechanical activity in horses.
Clark ES; Moore JN
Am J Vet Res; 1989 Nov; 50(11):1926-30. PubMed ID: 2575878
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
Eades SC; Moore JN
Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine administration on cecal mechanical activity and cecal blood flow in conscious healthy horses.
Clark ES; Moore JN
Am J Vet Res; 1989 Jul; 50(7):1084-8. PubMed ID: 2774332
[TBL] [Abstract][Full Text] [Related]
4. Blockade of endotoxin-induced cecal hypoperfusion and ileus with an alpha 2 antagonist in horses.
Eades SC; Moore JN
Am J Vet Res; 1993 Apr; 54(4):586-90. PubMed ID: 8484579
[TBL] [Abstract][Full Text] [Related]
5. Effects of xylazine on cecal mechanical activity and cecal blood flow in healthy horses.
Clark ES; Thompson SA; Becht JL; Moore JN
Am J Vet Res; 1988 May; 49(5):720-3. PubMed ID: 3395018
[TBL] [Abstract][Full Text] [Related]
6. The effects of slow infusion of a low dosage of endotoxin in healthy horses.
Clark ES; Moore JN
Equine Vet J Suppl; 1989 Jun; (7):33-7. PubMed ID: 9118103
[TBL] [Abstract][Full Text] [Related]
7. Human vasodilator responses to a dopamine agonist: possible mechanisms.
Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
[TBL] [Abstract][Full Text] [Related]
8. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
9. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Chen CJ; Apparsundaram S; Lokhandwala MF
J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
[TBL] [Abstract][Full Text] [Related]
10. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
[TBL] [Abstract][Full Text] [Related]
11. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
Zhao RR; Wang PH; Zhang WF; Fennell WH
Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
[TBL] [Abstract][Full Text] [Related]
13. Effects of xylazine butorphanol on cecal arterial blood flow, cecal mechanical activity, and systemic hemodynamics in horses.
Rutkowski JA; Eades SC; Moore JN
Am J Vet Res; 1991 Jul; 52(7):1153-8. PubMed ID: 1892272
[TBL] [Abstract][Full Text] [Related]
14. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
[TBL] [Abstract][Full Text] [Related]
16. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
17. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
Nichols AJ; Koster PF; Brooks DP; Ruffolo RR
J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Christie MI; Smith GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
[TBL] [Abstract][Full Text] [Related]
20. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
